Clinical Trial Update: Promoting Tolerance to Peanut in High-Risk Children [Phase 2]

View source ↗

Summary

Phase 2 trial update on promoting tolerance to peanut in high-risk children; completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Egg Allergy
• Food Allergy

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Eczema, Egg Allergy | Phase 2 | Status: COMPLETED | Results posted: 2016-12-28